Epidemiological and Histopathological Characterization of Endometrial Carcinoma: A Retrospective Cohort from Romania

<b>Background/Objectives</b>: Endometrial carcinoma is an emerging challenge for public health systems globally, especially in countries with a high development index. Traditionally, histopathological staging and grading have been the main criteria informing treatment modalities. More recently, clinically actionable molecular targets have been developed, following observations from the TCGA project and the ProMisE cohort. Although promising, the cost of these methods is an obstacle for some countries that lack well developed theranostics infrastructure in their public systems. This study aimed to contextualize our center's diagnostic experience from the perspective of histopathological diagnosis. <b>Methods</b>: This is a retrospective study that selected 109 cases of already diagnosed endometrial carcinoma from the interval of 2017-2023. We analyzed traditional parameters related to staging and grading, using the FIGO 2009 system as well as basic histological parameters (lymphovascular invasion, perineural invasion, necrosis). Excel and SPSS 26 were used for database management and correlations. Findings were contextualized using the more recent studies that reported on similar parameters. <b>Results</b>: Higher-grade tumors were associated with lymphovascular invasion (<i>p</i> = 0.04) and lymph node involvement (<i>p</i> = 0.0006), as well as deeper myoinvasion (<i>p</i> = 0.0018). Myoinvasion (<i>p</i> = 0.013) and lymphovascular invasion (<i>p</i> = 0.0001) were associated with advanced disease (FIGO III and IV). Our cohort showed a relative paucity (6.5%) of non-endometrioid endometrial carcinoma and presence of lymphovascular invasion (9.2%). Perineural invasion was found in 3 cases with extrauterine involvement. <b>Conclusions</b>: Histopathological diagnosis represents an integral component in informing clinical management for endometrial carcinoma and should serve as a means of triage for more expensive molecular techniques. It nevertheless presents reproducibility issues. Further efforts should focus on resolving such issues or possibly introducing less-researched parameters like perineural invasion.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2025-10-20
DOI
https://doi.org/10.3390/diagnostics15202645
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epidemiological and Histopathological Characterization of Endometrial Carcinoma: A Retrospective Cohort from Romania

Raluca Niculina Ciurea, Andrei Muraru, Ioana Crețu, Claudiu Mărgăritescu et al.
Diagnostics
Endometrial and Cervical Cancer Treatments
article

Epidemiological and Histopathological Characterization of Endometrial Carcinoma: A Retrospective Cohort from Romania

Raluca Niculina Ciurea, Andrei Muraru, Ioana Crețu, Claudiu Mărgăritescu, Bianca Cătălina Andreiana, Anne-Marie Badiu, Mirela Marinela Florescu, Alex-Emilian Stepan
article en

Abstract

<b>Background/Objectives</b>: Endometrial carcinoma is an emerging challenge for public health systems globally, especially in countries with a high development index. Traditionally, histopathological staging and grading have been the main criteria informing treatment modalities. More recently, clinically actionable molecular targets have been developed, following observations from the TCGA project and the ProMisE cohort. Although promising, the cost of these methods is an obstacle for some countries that lack well developed theranostics infrastructure in their public systems. This study aimed to contextualize our center's diagnostic experience from the perspective of histopathological diagnosis. <b>Methods</b>: This is a retrospective study that selected 109 cases of already diagnosed endometrial carcinoma from the interval of 2017-2023. We analyzed traditional parameters related to staging and grading, using the FIGO 2009 system as well as basic histological parameters (lymphovascular invasion, perineural invasion, necrosis). Excel and SPSS 26 were used for database management and correlations. Findings were contextualized using the more recent studies that reported on similar parameters. <b>Results</b>: Higher-grade tumors were associated with lymphovascular invasion (<i>p</i> = 0.04) and lymph node involvement (<i>p</i> = 0.0006), as well as deeper myoinvasion (<i>p</i> = 0.0018). Myoinvasion (<i>p</i> = 0.013) and lymphovascular invasion (<i>p</i> = 0.0001) were associated with advanced disease (FIGO III and IV). Our cohort showed a relative paucity (6.5%) of non-endometrioid endometrial carcinoma and presence of lymphovascular invasion (9.2%). Perineural invasion was found in 3 cases with extrauterine involvement. <b>Conclusions</b>: Histopathological diagnosis represents an integral component in informing clinical management for endometrial carcinoma and should serve as a means of triage for more expensive molecular techniques. It nevertheless presents reproducibility issues. Further efforts should focus on resolving such issues or possibly introducing less-researched parameters like perineural invasion.

DiagnosticsVol. 15(20)
University of Medicine and Pharmacy of Craiova (RO), University of Craiova (RO)
Openalex Percentile: Top 63%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.